Vasoconstricting effect of angiotensin II in human hand veins: Influence of aging, diabetes mellitus and hypertension

Hypertension Research

Volumn 25, Issue 5, 2002, Pages 683-688

  Harada, Kazuhiro ^a   Ohmori, Masami ^a   Fujimura, Akio ^a  

^a Kasaoka Daiichi Hospital   (Japan)

Author keywords

Aging; Angiotensin II; Diabetes mellitus; Hypertension; Tachyphylaxis

Indexed keywords

ANGIOTENSIN; NOR ADRENALINE; NORADRENALIN; ANGIOTENSIN II; VASOCONSTRICTOR AGENT;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; ESSENTIAL HYPERTENSION; GROUPS BY AGE; HAND; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TACHYPHYLAXIS; VEIN DIAMETER; VENOCONSTRICTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; VASOCONSTRICTION; VEIN;

ADULT; AGED; AGING; ANGIOTENSIN II; DIABETES MELLITUS, TYPE 2; HAND; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TACHYPHYLAXIS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VEINS;

EID: 0036747210     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.683     Document Type: Article

References (22)

1. Page IH, Bumps M: Angiotensin. Physiol Rev 1961; 41: 331-390.
2. Webb RC: Angiotensin II-induced relaxation of vascular smooth muscle. Blood Vessels 1982; 19: 165-176.
3. Aellig WH: Clinical pharmacology, physiology and pathophysiology of superficial veins-1. Br J Clin Pharmacol 1994; 38: 181-196.
4. Martin SA, Alexieva S, Carruthers SG: The influence of age on dorsal hand vein responsiveness to norepinephrine. Clin Pharmacol Ther 1986; 40: 257-260.
5. Harada K, Ohashi K, Kumagai Y, Ohmori M, Fujimura A: Influence of age on venodilator effect of isoproterenol and amrinone. Eur J Clin Pharmacol 1996; 50: 37-40.
6. Eichler HG, Ford GA, Blaschke TF, Swislocki A, Hoffman BB: Responsiveness of superficial hand veins to phenylephrine in essential hypertension-alpha adrenergic blockade during prazosin therapy. J Clin Invest 1989; 83: 108-112.
7. Feldman RD: Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest 1990; 85: 647-652.
8. Harada K, Ohmori M, Kitoh Y, Sugimoto K, Fujimura A: Impaired β-adrenoceptor mediated venodilation in patients with diabetes mellitus. Br J Clin Pharmacol 1999; 47: 427-431.
9. Collier JG, Nachev C, Robinson BF: Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin Sci 1972; 43:455-467.
10. Vincest J, Blaschke TF, Hoffman BB: Vascular reactivity to phenylephrine and angiotensin II: comparison of direct venous and systemic vascular responses. Clin Pharmacol Ther 1992; 51: 68-75.
11. Harada K, Ohmori M, Kitoh Y, Sugimoto K, Fujimura A: Effect of angiotensin II in human hand veins: development of rapid desensitization and influence of indomethacin. Clin Exp Pharmacol Physiol 1999; 26: 959-963.
12. Kuttan SC, Sim MK: Actions of noradrenaline and angiotensin II on aortic rings of adult and aged normotensive and hypertensive rats. J Cardiovasc Pharmacol 1993; 1: 371-375.
13. De Mey C, Vanhoutte PM: Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney. Hypertension 1981; 3: 718-724.
14. Hynes MR, Duckles SP: Effect of increasing age on the endothelium-mediated relaxation of rat blood vessels in vitro. J Pharmacol Exp Ther 1987; 241: 387-392.
15. Baan Jr J, Chang PC, Vermeij P, Pfaffendorf M, van Zwieten PA: Effects of angiotensin II and losartan in the forearm of patients with essential hypertension. J Hypertens 1998, 16: 1299-1305.
16. Duggan J, Nussberger J, Kilfeather S, O'malley K: Aging and human hormonal and pressor responsiveness to angiotensin II infusion with simultaneous measurement of exogenous and endogenous angiotensin II. Am J Hypertens 1993; 6: 641-647.
17. Anderson KM, Murahashi T, Dostal DE, Peach MJ: Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am J Physiol 1993; 264: C179-C188.
18. Kuttan SC, Sim MK: Angiotensin II-induced tachyphylaxis in aortas of normo- and hypertensive rats: changes in receptor affinity. Eur J Pharmacol 1993; 232: 173-180.
19. Chiba S, Tsukada M: Angiotensin II-induced tachyphylactic constrictions in isolated and perfused canine mesenteric arteries. Tohoku J Exp Med 1986; 150: 417-426.
20. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
21. Mizuno M, Sada T, Kato M, Koike H: Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes. Hypertes Res 2002; 25: 271-278.
22. Dahlof B, Devereux RB, Kjeldsen SE, et al: Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003.